AR and neoplasm: Whereas alterations in oncogenes and tumour suppressor genes (p53 loss, PTEN loss, PI3K mutations) that are shared across different tumour types can alter this process, enhanced lipid metabolism in PCa is predominantly driven by AR signalling [110, 111].